Biblio Discovery — Demo Discovery Service

3 hasil untuk "Mathilde Saint-Ghislain"

Menampilkan 1–3 · 0,49 detik · RSS

  1. Artikel Jurnal

    Adverse events of targeted therapies approved for women's cancers

    Mathilde Saint-Ghislain, MD; Chloé Levenbruck, PhD; Audrey Bellesoeur, MD

    International Journal of Women's Dermatology, Vol. 7 No. 5 · 2021 · Inggris · DOAJ Scopus

    Breast cancer and gynecologic cancers affect >3 million women worldwide each year. With advances in precision medicine, a growing number of targeted therapies have been approved recently, and new therapeutic classes have emerged, including cell cycle inhibitors for hormone receptor positive breast…

  2. Artikel Jurnal

    Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients

    Hélène Salaün; Leanne de Koning; Mathilde Saint-Ghislain dkk.

    OncoImmunology, Vol. 11 No. 1 · 2022 · Inggris · DOAJ Scopus

    Although combined PD-1/CTLA-4 inhibition showed limited efficacy in single-arm, phase II trials in metastatic uveal melanoma (mUM), such combination appears frequently used in mUM patients. We here report our experience with nivolumab/ipilimumab in mUM. A retrospective cohort of 47 mUM patients, 24…

  3. Artikel Jurnal

    Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO)

    Raphaël Leman; François Cherifi; Marianne Leheurteur dkk.

    BMC Cancer, Vol. 25 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Background The identification of homologous recombination deficient (HRD) tumor is now a crucial step for the therapeutic management of ovarian cancer. The HRD tumors are both sensitive to olaparib maintenance treatment and to platinum-based chemotherapy. Despite the large amount of HRD…